Jesús San Miguel is Professor of Medicine (Hematology) and Director of Clinical and Translational Medicine at the University of Navarra, Spain. He has served as Director of the Hematology Department at the University Hospital of Salamanca for over 22 years (1991–2013). His areas of interest include multiple myeloma, the biology of malignant cells and their prognostic implications, and minimal residual disease. He has made important contributions to myeloma cell biology (immunophenotyping, risk of progression from monoclonal gammopathy of undetermined significance or smouldering multiple myeloma into active multiple myeloma, minimal residual disease), as well as in the area of therapeutics (studies for new antimyeloma drugs at the preclinical and clinical levels: proteasome inhibitors, immunomodulary drugs, and histone deacetylases). Professor San Miguel is a member of the advisory boards of the International Myeloma Foundation and the Multiple Myeloma Research Foundation. He has served the European Hematology Association (EHA) as Board Councillor and Chair of the Scientific Committee for the 9th Congress (2004), and President of the 15th EHA Congress. He has published more than 700 original papers in international journals, and is Associate Editor of Blood and Haematologica. Professor San Miguel has received numerous prizes, including the Waldenström Award, Kyle Lifetime Achievement Award, EHA – José Carreras Award, Ham-Wasserman Lecture, Rey Jaime I Award for Clinical Medicine, and the Spanish Prizes in both Oncology and Translational Research.
You can see my upcoming and previous webinars here.
